Literature DB >> 2523911

D-penicillamine-induced elastosis perforans serpiginosa in a child with juvenile rheumatoid arthritis. Report of a case and review of the literature.

E E Sahn1, J C Maize, P D Garen, S C Mullins, R M Silver.   

Abstract

Elastosis perforans serpiginosa is a rare complication of D-penicillamine therapy. It has been reported to occur in Wilson's disease and cystinuria, usually after many years of high-dose therapy. We report a case of D-penicillamine-induced elastosis perforans serpiginosa with unique clinical features occurring in a 10-year-old child with juvenile rheumatoid arthritis who received only 71 gm of the drug over 9 months. The case is also unusual because of the short course and low cumulative dose of drug received and because of the calcification of elastic fibers. The calcification of elastic fibers suggests that this case may represent an unusual variant of elastosis perforans serpiginosa or an overlap with pseudoxanthoma elasticum. All reported cases of D-penicillamine-induced elastosis perforans serpiginosa are reviewed, and histopathologic and electron microscopic findings are presented. The theoretic mechanisms of action of D-penicillamine on elastic tissue synthesis and morphology are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523911     DOI: 10.1016/s0190-9622(89)70123-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  Penicillamine-induced Elastosis Perforans Serpiginosa and Cutis Laxa in a Patient with Wilson's Disease.

Authors:  Se Young Na; Mira Choi; Min Ji Kim; Jong Hee Lee; Soyun Cho
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

2.  Elastosis perforans serpiginosa.

Authors:  Si-Hyung Lee; Yuri Choi; Soo-Chan Kim
Journal:  Ann Dermatol       Date:  2014-02-17       Impact factor: 1.444

3.  Wilson's disease: an analysis of 28 Brazilian children.

Authors:  Rodolpho Truffa Kleine; Renata Mendes; Renata Pugliese; Irene Miura; Vera Danesi; Gilda Porta
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.